[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with Iron deficiency anemia.\nHF Categories:\n\nWithout heart failure\nHeart failure with reduced ejection fraction\nHeart failure with preserved ejection fraction\n\nICD Codes:\n\nHFrEF = I50.2 and I50.4\nHFpEF = I50.3\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with Iron deficiency anemia.\nHF Categories:\n\nWithout heart failure\nHeart failure with reduced ejection fraction\nHeart failure with preserved ejection fraction\n\nICD Codes:\n\nHFrEF = I50.2 and I50.4\nHFpEF = I50.3\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWithout heart failure\nN = 2,743,7051\nHeart failure with preserved ejection fraction\nN = 520,8851\nHeart failure with reduced ejection fraction\nN = 425,4051\np-value2\n\n\n\n\nAge, y\n58 (20)\n73 (13)\n70 (14)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n&lt;0.001\n\n\n    Female\n1,777,560 (65%)\n330,210 (63%)\n186,740 (44%)\n\n\n\n\n    Male\n965,955 (35%)\n190,655 (37%)\n238,655 (56%)\n\n\n\n\nRace\n\n\n\n\n\n\n&lt;0.001\n\n\n    White\n1,556,620 (58%)\n354,990 (70%)\n258,350 (62%)\n\n\n\n\n    Asian or Pacific Islander\n82,230 (3.1%)\n10,010 (2.0%)\n8,290 (2.0%)\n\n\n\n\n    Black\n600,870 (22%)\n94,210 (18%)\n100,970 (24%)\n\n\n\n\n    Hispanic\n332,010 (12%)\n37,305 (7.3%)\n35,570 (8.5%)\n\n\n\n\n    Native American\n23,455 (0.9%)\n3,025 (0.6%)\n2,855 (0.7%)\n\n\n\n\n    Other\n83,625 (3.1%)\n10,755 (2.1%)\n10,390 (2.5%)\n\n\n\n\nElixhauser comorbidity index\n4.86 (2.21)\n7.94 (1.98)\n7.91 (2.03)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n888,875 (33%)\n160,825 (31%)\n146,185 (35%)\n\n\n\n\n    $52,000 - $65,999\n707,520 (26%)\n137,745 (27%)\n111,610 (27%)\n\n\n\n\n    $66,000 - $87,999\n613,780 (23%)\n121,180 (24%)\n92,425 (22%)\n\n\n\n\n    $88,000 or more\n481,475 (18%)\n94,155 (18%)\n67,050 (16%)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n&lt;0.001\n\n\n    Private\n782,475 (29%)\n58,710 (11%)\n61,025 (14%)\n\n\n\n\n    Medicaid\n586,665 (21%)\n42,755 (8.2%)\n54,060 (13%)\n\n\n\n\n    Medicare\n1,305,760 (48%)\n411,755 (79%)\n301,790 (71%)\n\n\n\n\n    Other\n65,435 (2.4%)\n7,275 (1.4%)\n8,100 (1.9%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n621,480 (23%)\n148,350 (28%)\n113,875 (27%)\n\n\n\n\n    Northeast\n496,995 (18%)\n102,585 (20%)\n72,805 (17%)\n\n\n\n\n    South\n1,093,735 (40%)\n190,475 (37%)\n164,665 (39%)\n\n\n\n\n    West\n531,495 (19%)\n79,475 (15%)\n74,060 (17%)\n\n\n\n\nHypertension\n1,547,895 (56%)\n42,155 (8.1%)\n29,455 (6.9%)\n&lt;0.001\n\n\nHyperlipidemia\n891,295 (32%)\n299,290 (57%)\n240,825 (57%)\n&lt;0.001\n\n\nPeripheral vascular disease\n177,945 (6.5%)\n67,155 (13%)\n102,640 (24%)\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n600,035 (22%)\n234,725 (45%)\n159,285 (37%)\n&lt;0.001\n\n\nCoronary artery disease\n394,015 (14%)\n220,005 (42%)\n240,850 (57%)\n&lt;0.001\n\n\nDementia\n194,255 (7.1%)\n53,610 (10%)\n35,555 (8.4%)\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n1,106,395 (40%)\n253,820 (49%)\n209,790 (49%)\n&lt;0.001\n\n\nValvular heart disease\n80,765 (2.9%)\n70,515 (14%)\n61,135 (14%)\n&lt;0.001\n\n\nAtrial fibrillation\n276,410 (10%)\n198,540 (38%)\n160,570 (38%)\n&lt;0.001\n\n\nObesity\n497,640 (18%)\n156,735 (30%)\n92,240 (22%)\n&lt;0.001\n\n\nPresence of pacemaker\n54,265 (2.0%)\n44,780 (8.6%)\n82,540 (19%)\n&lt;0.001\n\n\nprevious MI\n109,195 (4.0%)\n56,800 (11%)\n83,995 (20%)\n&lt;0.001\n\n\nPior cardiac surgery\n99,390 (3.6%)\n70,565 (14%)\n77,805 (18%)\n&lt;0.001\n\n\nMalnutrition\n323,035 (12%)\n49,315 (9.5%)\n47,560 (11%)\n&lt;0.001\n\n\nCancer\n287,150 (10%)\n31,260 (6.0%)\n25,995 (6.1%)\n&lt;0.001\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWithout heart failure\nN = 2,743,7051\nHeart failure with preserved ejection fraction\nN = 520,8851\nHeart failure with reduced ejection fraction\nN = 425,4051\np-value2\n\n\n\n\nDied during hospitalization\n46,190 (1.7%)\n15,395 (3.0%)\n16,390 (3.9%)\n&lt;0.001\n\n\nLength of stay (days)\n5.8 (7.6)\n6.9 (7.1)\n7.5 (8.6)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n66,606 (100,022)\n74,877 (98,061)\n92,846 (156,520)\n&lt;0.001\n\n\n\n1 n (%); Mean (SD)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test\n\n\n\n\n\n\n\n\n\nMultivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    Heart failure with preserved ejection fraction\n0.54\n0.51, 0.58\n&lt;0.001\n\n\n    Heart failure with reduced ejection fraction\n0.76\n0.71, 0.81\n&lt;0.001\n\n\nAge, y\n1.03\n1.03, 1.04\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.21\n1.17, 1.26\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.27\n1.16, 1.40\n&lt;0.001\n\n\n    Black\n1.03\n0.98, 1.08\n0.3\n\n\n    Hispanic\n1.10\n1.04, 1.17\n0.002\n\n\n    Native American\n0.77\n0.60, 0.99\n0.039\n\n\n    Other\n1.19\n1.08, 1.32\n&lt;0.001\n\n\nElixhauser comorbidity index\n1.33\n1.32, 1.35\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.92\n0.88, 0.96\n&lt;0.001\n\n\n    $66,000 - $87,999\n0.86\n0.82, 0.90\n&lt;0.001\n\n\n    $88,000 or more\n0.83\n0.79, 0.88\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.88\n0.83, 0.94\n&lt;0.001\n\n\n    Medicare\n0.75\n0.71, 0.79\n&lt;0.001\n\n\n    Other\n1.45\n1.29, 1.62\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.18\n1.11, 1.26\n&lt;0.001\n\n\n    South\n0.93\n0.89, 0.98\n0.010\n\n\n    West\n0.98\n0.92, 1.04\n0.5\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.56\n0.53, 0.58\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.70\n0.67, 0.73\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.90\n0.85, 0.95\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.91, 1.0\n0.029\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.81\n0.78, 0.84\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.75, 0.86\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.12\n1.07, 1.18\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.41\n1.34, 1.48\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.27\n2.17, 2.37\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.11\n1.06, 1.16\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.64, 0.71\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.66\n0.61, 0.71\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.91, 1.04\n0.4\n\n\nMalnutrition\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.40\n1.34, 1.46\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.75, 0.86\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\n\nMultivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    Heart failure with preserved ejection fraction\n-0.12\n-0.20, -0.04\n0.005\n\n\n    Heart failure with reduced ejection fraction\n0.41\n0.31, 0.50\n&lt;0.001\n\n\nAge, y\n-0.01\n-0.01, -0.01\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.72\n0.68, 0.76\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.20\n0.05, 0.35\n0.008\n\n\n    Black\n0.26\n0.19, 0.32\n&lt;0.001\n\n\n    Hispanic\n-0.03\n-0.12, 0.05\n0.5\n\n\n    Native American\n-0.03\n-0.29, 0.24\n0.8\n\n\n    Other\n0.44\n0.29, 0.59\n&lt;0.001\n\n\nElixhauser comorbidity index\n0.54\n0.53, 0.56\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.08\n-0.14, -0.03\n0.003\n\n\n    $66,000 - $87,999\n-0.06\n-0.12, 0.00\n0.066\n\n\n    $88,000 or more\n-0.01\n-0.09, 0.07\n0.8\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.52\n0.45, 0.59\n&lt;0.001\n\n\n    Medicare\n0.07\n0.01, 0.13\n0.026\n\n\n    Other\n0.42\n0.28, 0.57\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.79\n0.67, 0.90\n&lt;0.001\n\n\n    South\n0.27\n0.18, 0.36\n&lt;0.001\n\n\n    West\n-0.08\n-0.19, 0.04\n0.2\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.26\n-0.31, -0.21\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.35\n-0.39, -0.30\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.01\n-0.08, 0.06\n0.8\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.08\n-0.13, -0.02\n0.003\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.57\n-0.62, -0.53\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.30\n-0.38, -0.22\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.73\n0.65, 0.82\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.05\n-0.02, 0.12\n0.2\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.4\n1.3, 1.4\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.07\n0.01, 0.12\n0.014\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.08\n-0.14, -0.03\n0.002\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.0\n-1.1, -0.92\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.48\n-0.55, -0.41\n&lt;0.001\n\n\nMalnutrition\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3.1\n3.0, 3.2\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.70\n-0.76, -0.63\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    Heart failure with preserved ejection fraction\n-5,792\n-7,343, -4,241\n&lt;0.001\n\n\n    Heart failure with reduced ejection fraction\n9,682\n7,369, 11,995\n&lt;0.001\n\n\nAge, y\n-172\n-202, -142\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n8,898\n8,280, 9,517\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n10,685\n7,906, 13,464\n&lt;0.001\n\n\n    Black\n2,992\n1,800, 4,184\n&lt;0.001\n\n\n    Hispanic\n11,624\n9,650, 13,599\n&lt;0.001\n\n\n    Native American\n-15,147\n-18,155, -12,138\n&lt;0.001\n\n\n    Other\n16,330\n13,095, 19,565\n&lt;0.001\n\n\nElixhauser comorbidity index\n6,430\n5,999, 6,861\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-50\n-1,125, 1,024\n&gt;0.9\n\n\n    $66,000 - $87,999\n1,544\n246, 2,842\n0.020\n\n\n    $88,000 or more\n6,400\n4,528, 8,271\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-3,968\n-5,022, -2,915\n&lt;0.001\n\n\n    Medicare\n-4,140\n-5,075, -3,204\n&lt;0.001\n\n\n    Other\n1,724\n-818, 4,265\n0.2\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n17,787\n14,764, 20,810\n&lt;0.001\n\n\n    South\n11,199\n9,274, 13,124\n&lt;0.001\n\n\n    West\n33,846\n30,205, 37,487\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-631\n-1,484, 222\n0.15\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-831\n-1,541, -121\n0.022\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n4,017\n2,784, 5,250\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n7,915\n7,010, 8,821\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-7,325\n-8,157, -6,493\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n10,145\n8,586, 11,704\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-6,007\n-7,000, -5,014\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n4,476\n3,371, 5,580\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n16,042\n15,191, 16,893\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2,985\n2,113, 3,857\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1,855\n980, 2,729\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-16,482\n-17,871, -15,092\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,317\n-11,423, -9,211\n&lt;0.001\n\n\nMalnutrition\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n31,373\n29,388, 33,358\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-14,321\n-15,406, -13,236\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]